Endocyte extends morning gains

Shares of Endocyte (ECYT +28.3%) have built on early gains and are now up sharply in afternoon trading.

The stock got a positive mention today from SA contributor StockMatusow, who includes the company on a list of "biotechs with near-term catalysts that should rally."

Comments (1)
  • Scientist on Stocks
    , contributor
    Comments (366) | Send Message
    Why skip CHTP down 30% was also mentioned positively by StockMatusow in the same article?
    10 Jan 2014, 03:08 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs